Author

Kim Mirjafary

Institutions: Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center

Observed institutions: Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center

OpenAlex ID: A5069576704

In Vivo Correlates of Response for Phase I Trial of Oral Tipifarnib (T) Combined with Oral Etoposide (E) for Adults Age ≥ 70 with Newly Diagnosed Acute Myelogenous Leukemia (AML) Who Are Not Candidates for Traditional Cytotoxic Chemotherapy (TCC).

2007 · Rebecca M. Ricklis, Judith E. Karp, et al. · Blood · 5

Works count: 1

Citation count: 5

H-index: 1

I10-index: